BMT-124110 Formate NEW
| Price | $195 | $430 | $636 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-06 |
Product Details
| Product Name: BMT-124110 Formate | Purity: 99.52% |
| Supply Ability: 10g | Release date: 2026/05/06 |
Product Introduction
Bioactivity
| Name | BMT-124110 Formate |
| Description | BMT-124110 Formate is a selective AAK1 inhibitor (IC50: 0.9 nM) with anti-injury sensory activity.BMT-124110 Formate inhibits the BMP-2-inducible protein kinase BIKE with an IC50: 17 nM.BMT-124110 Formate inhibits the cell-cycle protein G-related BMT-124110 Formate inhibits the cell cycle protein G-associated kinase GAK with an IC50:99 nM. |
| In vitro | BMT-124110 exhibits a cellular IC50 of 3.2±1.4 nM against AAK1.[1] |
| In vivo | BMT-124110 (30 mM; pH 4; 110–30 nA; 3 minutes; naive male rats) is added directly onto the spinal covered by micro iontophoresis, leading to a reduction in windup-induced activity in 10/14 animals.[1] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 4.15 mg/mL (12.05 mM), Sonication is recommended. |
| Keywords | threoninkinase | threonin kinase | TGF-β/Smad | TGFβ | TGFbeta/Smad | TGF-beta | TGFbeta | TGF-b/Smad | TGFb | Smad | Serinekinase | Serine kinase | GAK | bone morphogenetic protein (BMP) | BMT-124110 Formate | BMT124110 Formate | BMT 124110 Formate | BIKE | AP2associatedkinase1 | AP2 associated kinase 1 | AAK1(AP2associatedkinase1) | AAK1 (AP2 associated kinase 1) | AAK1 | 1679371-59-5 Free base | 1679371-59-5 |
| Inhibitors Related | Melamine | SB-431542 | Hydrochlorothiazide | Chymotrypsin | Fasudil hydrochloride | Pirfenidone | A 83-01 | Cetrimonium bromide | Galunisertib | FOY 251 | Alantolactone | Benzamidine hydrochloride |
| Related Compound Libraries | Reprogramming Compound Library | Bioactive Compound Library | Neuronal Signaling Compound Library | Membrane Protein-targeted Compound Library | HIF-1 Signaling Pathway Compound Library | Kinase Inhibitor Library | Anti-Breast Cancer Compound Library | Angiogenesis related Compound Library | Inhibitor Library | Stem Cell Differentiation Compound Library | Bioactive Compounds Library Max | TGF-beta/Smad Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $329.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-06 | |
| $329.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-28 | |
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-04 | ||
| $195.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-06 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY